A landscape analysis of Japanese tolerability assessments in oncology drug development

Hiroe Kitagaki, Kentaro Takeda, Hanami Nojiri, Hideki Maeda

Open source

DOI
10.1016/j.ctarc.2026.101417
Published
2026
Container
Cancer Treatment and Research Communications
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2026.101417,
  title = {A landscape analysis of Japanese tolerability assessments in oncology drug development},
  author = {Hiroe Kitagaki and Kentaro Takeda and Hanami Nojiri and Hideki Maeda},
  year = {2026},
  journal = {Cancer Treatment and Research Communications},
  doi = {10.1016/j.ctarc.2026.101417},
  url = {https://doi.org/10.1016/j.ctarc.2026.101417}
}

RIS

TY  - JOUR
TI  - A landscape analysis of Japanese tolerability assessments in oncology drug development
AU  - Hiroe Kitagaki
AU  - Kentaro Takeda
AU  - Hanami Nojiri
AU  - Hideki Maeda
PY  - 2026
JO  - Cancer Treatment and Research Communications
DO  - 10.1016/j.ctarc.2026.101417
UR  - https://doi.org/10.1016/j.ctarc.2026.101417
ER  - 

APA

Kitagaki, H., Takeda, K., Nojiri, H., & Maeda, H. (2026). A landscape analysis of Japanese tolerability assessments in oncology drug development. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101417

Source records